CRIS Current Research Information System

ZAMAGNI, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.494
NA - Nord America 1.866
EU - Europa 1.399
AF - Africa 167
SA - Sud America 95
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.027
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.842
VN - Vietnam 729
CN - Cina 621
SG - Singapore 619
IT - Italia 496
GB - Regno Unito 168
SE - Svezia 155
HK - Hong Kong 143
DE - Germania 130
KR - Corea 106
IN - India 92
NL - Olanda 89
FR - Francia 65
BR - Brasile 64
CI - Costa d'Avorio 63
RU - Federazione Russa 56
IE - Irlanda 45
FI - Finlandia 41
JP - Giappone 33
BG - Bulgaria 31
TG - Togo 26
PH - Filippine 24
SC - Seychelles 24
UA - Ucraina 23
JO - Giordania 21
CH - Svizzera 20
ZA - Sudafrica 20
AT - Austria 18
ID - Indonesia 18
AR - Argentina 17
CA - Canada 17
BD - Bangladesh 15
PL - Polonia 15
BE - Belgio 14
EE - Estonia 9
TH - Thailandia 9
UZ - Uzbekistan 9
EG - Egitto 8
TR - Turchia 8
TW - Taiwan 8
ES - Italia 7
EC - Ecuador 6
IQ - Iraq 5
MX - Messico 5
NG - Nigeria 5
OM - Oman 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
MY - Malesia 4
NP - Nepal 4
IR - Iran 3
KE - Kenya 3
NO - Norvegia 3
PK - Pakistan 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
VE - Venezuela 3
AZ - Azerbaigian 2
ET - Etiopia 2
IL - Israele 2
LT - Lituania 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
CL - Cile 1
CO - Colombia 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
GN - Guinea 1
HR - Croazia 1
KH - Cambogia 1
LB - Libano 1
LC - Santa Lucia 1
MA - Marocco 1
ML - Mali 1
NA - Namibia 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 6.027
Salva come PNG Salva come JPEG
Città #
Singapore 450
Ashburn 277
Hefei 206
Ho Chi Minh City 177
Hanoi 150
Fairfield 142
Chandler 133
Hong Kong 133
Southend 130
Bologna 125
San Jose 100
Seoul 99
Santa Clara 73
Houston 67
Wilmington 65
Beijing 64
Abidjan 63
Seattle 60
Woodbridge 60
New York 55
Dallas 52
Ann Arbor 47
Cambridge 46
Los Angeles 46
Dublin 45
Boardman 43
Princeton 42
Haiphong 36
Helsinki 36
Council Bluffs 32
Tokyo 29
Da Nang 28
Sofia 28
Lauterbourg 27
Lomé 26
Milan 25
Frankfurt am Main 24
Hyderabad 24
Dong Ket 23
Amman 21
Bengaluru 19
Florence 19
Nanjing 18
Berlin 16
Bern 16
Turin 16
Shanghai 15
Vienna 15
Westminster 15
Amsterdam 14
Chicago 13
Jakarta 13
Redondo Beach 13
Saint Petersburg 13
Buffalo 12
Guangzhou 12
Padova 12
Brussels 11
Jacksonville 10
Jinan 10
Warsaw 10
Casalecchio di Reno 9
Cesena 9
Falkenstein 9
Falls Church 9
Hải Dương 9
Munich 9
Redmond 9
São Paulo 9
Tongling 9
London 8
Ninh Bình 8
Nuremberg 8
Rome 8
Johannesburg 7
Lugo 7
Tashkent 7
Tân Tiến 7
Atlanta 6
Biên Hòa 6
Boydton 6
Bắc Ninh 6
Changsha 6
Forlì 6
Hebei 6
Nanchang 6
Nha Trang 6
Phoenix 6
San Diego 6
Shenyang 6
Verona 6
Abeokuta 5
Bangkok 5
Bến Tre 5
Chengdu 5
Chennai 5
Des Moines 5
Hangzhou 5
Montreal 5
Ningbo 5
Totale 3.865
Salva come PNG Salva come JPEG
Nome #
Mitochondrial DNA genotyping efficiently reveals clonality of synchronous endometrial and ovarian cancers 296
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma 278
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach 269
Management of malignant cutaneous wounds in oncologic patients 251
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice 239
Allogenic sternal transplant after sternectomy for metastasis of ovarian carcinoma. 235
A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results 233
COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak 220
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification 216
Mitochondrial DNA Mutation in Serous Ovarian Cancer: Implications for Mitochondria-Coded Genes in Chemoresistance 204
Liquid biopsy in the diagnosis of HPV DNA in breast lesions 204
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: A case report 198
Relevance of ARID1A Mutations in Endometrial Carcinomas 193
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 192
Classical Prognostic Factors Predict Prognosis Better than Inflammatory Indices in Locally Advanced Cervical Cancer: Results of a Comprehensive Observational Study including Tumor-, Patient-, and Treatment-Related Data (ESTHER Study) 172
[18F]FDG-PET/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy. 171
Combination of Electrochemotherapy with Radiotherapy: A Comprehensive, Systematic, PRISMA-Compliant Review of Efficacy and Potential Radiosensitizing Effects in Tumor Control 170
HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer 169
FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy. 166
A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed 164
Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and overall survival 156
The Neoadjuvant Net: a patient- and surgeon-friendly device to facilitate safe breast-conserving surgery in patients who underwent neoadjuvant treatment 156
Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going 155
Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma 152
null 150
Characterization of BRCA Deficiency in Ovarian Cancer 143
Hyperthermic Intraperitoneal Chemotherapy in Ephitelial Ovarian Cancer should be proposed in eight time points. 131
Radiotherapy in uterine sarcoma: a narrative review of international guidelines 124
Exploring pain management in breast cancer: key findings from the ARISE study 120
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 113
Factors predicting BRCA1/2 pathogenic variants in patients with ovarian cancer: a systematic review with meta-analysis 100
Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System 93
High-grade serous carcinoma: a comprehensive genetic and clinico-pathologic study of a heterogeneous neoplasm. 81
Integrated Molecular and Clinicopathologic Study of Tubo-Ovarian High-Grade Serous Carcinoma 80
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype 77
ESR1 analysis of liquid biopsy in breast cancer, one-year routine experience of an Italian clinical referral center 55
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study 28
Totale 6.154
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.250
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021133 0 0 0 0 0 0 0 0 0 10 14 109
2021/2022494 42 23 31 54 43 18 11 30 22 60 99 61
2022/2023579 54 93 30 52 37 41 17 27 112 15 44 57
2023/2024299 31 28 15 14 16 77 11 46 11 12 16 22
2024/20251.135 104 86 112 63 102 56 98 74 28 104 108 200
2025/20262.713 254 396 226 235 252 120 421 91 548 170 0 0
Totale 6.154